Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (“Theseus” or the “Company”), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative targeted therapies, announces that Concentra Biosciences, LLC (“Concentra”) through its wholly owned subsidiary, Concentra Merger Sub II, Inc. (“Merger Sub”), has successfully completed the previously announced tender offer to acquire all outstanding shares of Theseus common stock. As a result of the Merger, Theseus became a wholly owned subsidiary of Concentra.
Read the full article: Concentra Biosciences Completes Acquisition of Theseus Pharmaceuticals //
Source: https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-announces-closing-of-tender-offer-302061474.html